Quality of life measurement in breast cancer patients.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001294:Attitude to Health; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D011446:Prospective Studies; D011788:Quality of Life
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate